Highly Efficient Expansion of Human CD4+CD25+ Regulatory T Cells for Cellular Immunotherapy in Patients with Graft-Versus-Host Disease
Authors:
- Markus MunderMMMarkus Munder
- Markus SchneiderMSMarkus Schneider
- Anthony D. HoAnthony D. Ho
- Martin GoernerMGMartin Goerner
- 1 May 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 29 (3) , 336-349
Abstract
CD4+CD25+ regulatory T cells (TREG) are engaged in the regulation of murine and human immune responses as well as graft-versus-host disease (GvHD) after allogeneic stem-cell transplantation. Despite their suppression of GvHD they do not impair graft-versus-tumor activity in the mouse, which makes TREG especially attractive candidates for cellular immunotherapy. TREG comprise only 5% to 10% of CD4+ T cells in peripheral blood and are naturally anergic, which prevented their use as therapeutic suppressor cells in the context of autoimmune or alloimmune reactions so far. We therefore developed an in vitro expansion protocol for human TREG, breaking their anergy with anti-CD3/anti-CD28–coupled paramagnetic beads and a combination of interleukin (IL)-2 and IL-15. Highly purified human TREG can be expanded 285-fold to 1000-fold within 20 days and keep their phenotype as well as all their suppressor functions even in the context of stimulation with mature allogeneic dendritic cells. However, we demonstrate that FoxP3 is not a reliable marker for human TREG as it is transiently inducible in CD4+CD25− cells upon activation with cytokines or via their T cell receptor. In addition, we successfully expanded CD4+CD25+ cells from patients after allogeneic stem-cell transplantation with or without GvHD and show that different suppressor functions might be lost independently, demonstrating that human TREG biology is likely more complicated than previously thought.Keywords
This publication has 67 references indexed in Scilit:
- Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cellsBlood, 2004
- Human CD4+CD25+ regulatory T cellsSeminars in Immunology, 2004
- Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T cellsBlood, 2004
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 Journal of Experimental Medicine, 2003
- Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivoBlood, 2003
- CD4+CD25+ Immunoregulatory T CellsJournal of Experimental Medicine, 2002
- Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trialBlood, 2002
- Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivoNature Immunology, 2001
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βJournal of Experimental Medicine, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999